Continuity of cancer care: The surgical experience of two large cancer hubs in london and milan

Maria Monroy Iglesias; Marta Tagliabue; Harvey Dickinson; Graham Roberts; Rita De Berardinis; Beth Russell; Charlotte Moss; Sophie Irwin; Jonathon Olsburgh; Ivana Maria Francesca Cocco; Alexis M. P. Schizas; Sarah McCrindle; Rahul Nath; Aina Brunet; Ricard Simo; Chrysostomos Tornari; Parthi Srinivasan; Andreas Prachalias; Andrew Davies; Jenny  Geh; Stephanie Fraser; Tom Routledge; Rujun Ma; Ella Doerge; Ben Challacombe; Raj Nair; Marios Hadjipavlou; Rosaria Scarpinata; Paolo Sorelli; Saoirse Dolly; Francesco Alessandro Mistretta; Gennaro Musi; Monica Casiraghi; Alessia Aloisi; Andrea Dell’acqua; Donatella Scaglione; Stefania Zanoni; Daniele Rampazio Da Silva; Daniela Brambilla; Raffaella Bertolotti; Giulia Peruzzotti; Angelo Maggioni; Ottavio De Cobelli; Lorenzo Spaggiari; Mohssen Ansarin; Fabrizio Mastrilli; Sara Gandini; Urvashi Jain; Hisham Hamed; Kate Haire; Mieke Van Hemelrijck

doi:10.3390/cancers13071597

Continuity of cancer care: The surgical experience of two large cancer hubs in london and milan

Maria Monroy Iglesias, Marta Tagliabue, Harvey Dickinson, Graham Roberts, Rita De Berardinis, Beth Russell, Charlotte Moss, Sophie Irwin, Jonathon Olsburgh, Ivana Maria Francesca Cocco, Alexis M. P. Schizas, Sarah McCrindle, Rahul Nath, Aina Brunet, Ricard Simo, Chrysostomos Tornari, Parthi Srinivasan, Andreas Prachalias, Andrew Davies, Jenny GehStephanie Fraser, Tom Routledge, Rujun Ma, Ella Doerge, Ben Challacombe, Raj Nair, Marios Hadjipavlou, Rosaria Scarpinata, Paolo Sorelli, Saoirse Dolly, Francesco Alessandro Mistretta, Gennaro Musi, Monica Casiraghi, Alessia Aloisi, Andrea Dell’acqua, Donatella Scaglione, Stefania Zanoni, Daniele Rampazio Da Silva, Daniela Brambilla, Raffaella Bertolotti, Giulia Peruzzotti, Angelo Maggioni, Ottavio De Cobelli, Lorenzo Spaggiari, Mohssen Ansarin, Fabrizio Mastrilli, Sara Gandini, Urvashi Jain, Hisham Hamed, Kate Haire, Mieke Van Hemelrijck

Comprehensive Cancer Centre

Research output: Contribution to journal › Article › peer-review

16 Citations (Scopus)

Abstract

The SARS-CoV-2 (COVID-19) pandemic is having a large effect on the management of cancer patients. This study reports on the approach and outcomes of cancer patients receiving radical surgery with curative intent between March and September 2020 (in comparison to 2019) in the European Institute of Oncology, IRCCS (IEO) in Milan and the South East London Cancer Alliance (SELCA). Both institutions implemented a COVID-19 minimal pathway where patients were required to self-isolate prior to admission and were swabbed for COVID-19 within 72 h of surgery. Positive patients had surgery deferred until a negative swab. At IEO, radical surgeries declined by 6% as compared to the same period in 2019 (n = 1477 vs. 1560, respectively). Readmissions were required for 3% (n = 41), and <1% (n = 9) developed COVID-19, of which only one had severe disease and died. At SELCA, radical surgeries declined by 34% (n = 1553 vs. 2336). Readmissions were required for 11% (n = 36), <1% (n = 7) developed COVID-19, and none died from it. Whilst a decline in number of surgeries was observed in both centres, the implemented COVID-19 minimal pathways have shown to be safe for cancer patients requiring radical treatment, with limited complications and almost no COVID-19 infections.

Original language	English
Article number	1597
Journal	Cancers
Volume	13
Issue number	7
DOIs	https://doi.org/10.3390/cancers13071597
Publication status	Published - 1 Apr 2021

Keywords

Cancer surgery
COVID-19
Postoperative outcomes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3390/cancers13071597

Cite this

Monroy Iglesias, M., Tagliabue, M., Dickinson, H., Roberts, G., De Berardinis, R., Russell, B., Moss, C., Irwin, S., Olsburgh, J., Cocco, I. M. F., Schizas, A. M. P., McCrindle, S., Nath, R., Brunet, A., Simo, R., Tornari, C., Srinivasan, P., Prachalias, A., Davies, A., ... Van Hemelrijck, M. (2021). Continuity of cancer care: The surgical experience of two large cancer hubs in london and milan. Cancers, 13(7), Article 1597. https://doi.org/10.3390/cancers13071597

@article{2d43e1964dd3412b85fbe4aa36b9f7b4,

title = "Continuity of cancer care: The surgical experience of two large cancer hubs in london and milan",

abstract = "The SARS-CoV-2 (COVID-19) pandemic is having a large effect on the management of cancer patients. This study reports on the approach and outcomes of cancer patients receiving radical surgery with curative intent between March and September 2020 (in comparison to 2019) in the European Institute of Oncology, IRCCS (IEO) in Milan and the South East London Cancer Alliance (SELCA). Both institutions implemented a COVID-19 minimal pathway where patients were required to self-isolate prior to admission and were swabbed for COVID-19 within 72 h of surgery. Positive patients had surgery deferred until a negative swab. At IEO, radical surgeries declined by 6% as compared to the same period in 2019 (n = 1477 vs. 1560, respectively). Readmissions were required for 3% (n = 41), and <1% (n = 9) developed COVID-19, of which only one had severe disease and died. At SELCA, radical surgeries declined by 34% (n = 1553 vs. 2336). Readmissions were required for 11% (n = 36), <1% (n = 7) developed COVID-19, and none died from it. Whilst a decline in number of surgeries was observed in both centres, the implemented COVID-19 minimal pathways have shown to be safe for cancer patients requiring radical treatment, with limited complications and almost no COVID-19 infections.",

keywords = "Cancer surgery, COVID-19, Postoperative outcomes",

author = "{Monroy Iglesias}, Maria and Marta Tagliabue and Harvey Dickinson and Graham Roberts and {De Berardinis}, Rita and Beth Russell and Charlotte Moss and Sophie Irwin and Jonathon Olsburgh and Cocco, {Ivana Maria Francesca} and Schizas, {Alexis M. P.} and Sarah McCrindle and Rahul Nath and Aina Brunet and Ricard Simo and Chrysostomos Tornari and Parthi Srinivasan and Andreas Prachalias and Andrew Davies and Jenny Geh and Stephanie Fraser and Tom Routledge and Rujun Ma and Ella Doerge and Ben Challacombe and Raj Nair and Marios Hadjipavlou and Rosaria Scarpinata and Paolo Sorelli and Saoirse Dolly and Mistretta, {Francesco Alessandro} and Gennaro Musi and Monica Casiraghi and Alessia Aloisi and Andrea Dell{\textquoteright}acqua and Donatella Scaglione and Stefania Zanoni and {Da Silva}, {Daniele Rampazio} and Daniela Brambilla and Raffaella Bertolotti and Giulia Peruzzotti and Angelo Maggioni and {De Cobelli}, Ottavio and Lorenzo Spaggiari and Mohssen Ansarin and Fabrizio Mastrilli and Sara Gandini and Urvashi Jain and Hisham Hamed and Kate Haire and {Van Hemelrijck}, Mieke",

note = "Funding Information: This work was partially supported by the Italian Ministry of Health with Ricerca Corrente and 5 ? 1000 funds. Funding Information: Funding: This work was partially supported by the Italian Ministry of Health with Ricerca Corrente and 5 × 1000 funds. Publisher Copyright: {\textcopyright} 2021 by the authors. Licensee MDPI, Basel, Switzerland. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",

year = "2021",

month = apr,

day = "1",

doi = "10.3390/cancers13071597",

language = "English",

volume = "13",

journal = "Cancers",

issn = "2072-6694",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "7",

}

Monroy Iglesias, M, Tagliabue, M, Dickinson, H, Roberts, G, De Berardinis, R, Russell, B , Moss, C, Irwin, S, Olsburgh, J, Cocco, IMF, Schizas, AMP, McCrindle, S, Nath, R, Brunet, A, Simo, R, Tornari, C, Srinivasan, P, Prachalias, A, Davies, A, Geh, J, Fraser, S, Routledge, T, Ma, R, Doerge, E, Challacombe, B, Nair, R, Hadjipavlou, M, Scarpinata, R, Sorelli, P, Dolly, S, Mistretta, FA, Musi, G, Casiraghi, M, Aloisi, A, Dell’acqua, A, Scaglione, D, Zanoni, S, Da Silva, DR, Brambilla, D, Bertolotti, R, Peruzzotti, G, Maggioni, A, De Cobelli, O, Spaggiari, L, Ansarin, M, Mastrilli, F, Gandini, S, Jain, U, Hamed, H, Haire, K & Van Hemelrijck, M 2021, 'Continuity of cancer care: The surgical experience of two large cancer hubs in london and milan', Cancers, vol. 13, no. 7, 1597. https://doi.org/10.3390/cancers13071597

TY - JOUR

T1 - Continuity of cancer care

T2 - The surgical experience of two large cancer hubs in london and milan

AU - Monroy Iglesias, Maria

AU - Tagliabue, Marta

AU - Dickinson, Harvey

AU - Roberts, Graham

AU - De Berardinis, Rita

AU - Russell, Beth

AU - Moss, Charlotte

AU - Irwin, Sophie

AU - Olsburgh, Jonathon

AU - Cocco, Ivana Maria Francesca

AU - Schizas, Alexis M. P.

AU - McCrindle, Sarah

AU - Nath, Rahul

AU - Brunet, Aina

AU - Simo, Ricard

AU - Tornari, Chrysostomos

AU - Srinivasan, Parthi

AU - Prachalias, Andreas

AU - Davies, Andrew

AU - Geh, Jenny

AU - Fraser, Stephanie

AU - Routledge, Tom

AU - Ma, Rujun

AU - Doerge, Ella

AU - Challacombe, Ben

AU - Nair, Raj

AU - Hadjipavlou, Marios

AU - Scarpinata, Rosaria

AU - Sorelli, Paolo

AU - Dolly, Saoirse

AU - Mistretta, Francesco Alessandro

AU - Musi, Gennaro

AU - Casiraghi, Monica

AU - Aloisi, Alessia

AU - Dell’acqua, Andrea

AU - Scaglione, Donatella

AU - Zanoni, Stefania

AU - Da Silva, Daniele Rampazio

AU - Brambilla, Daniela

AU - Bertolotti, Raffaella

AU - Peruzzotti, Giulia

AU - Maggioni, Angelo

AU - De Cobelli, Ottavio

AU - Spaggiari, Lorenzo

AU - Ansarin, Mohssen

AU - Mastrilli, Fabrizio

AU - Gandini, Sara

AU - Jain, Urvashi

AU - Hamed, Hisham

AU - Haire, Kate

AU - Van Hemelrijck, Mieke

N1 - Funding Information: This work was partially supported by the Italian Ministry of Health with Ricerca Corrente and 5 ? 1000 funds. Funding Information: Funding: This work was partially supported by the Italian Ministry of Health with Ricerca Corrente and 5 × 1000 funds. Publisher Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.

PY - 2021/4/1

Y1 - 2021/4/1

N2 - The SARS-CoV-2 (COVID-19) pandemic is having a large effect on the management of cancer patients. This study reports on the approach and outcomes of cancer patients receiving radical surgery with curative intent between March and September 2020 (in comparison to 2019) in the European Institute of Oncology, IRCCS (IEO) in Milan and the South East London Cancer Alliance (SELCA). Both institutions implemented a COVID-19 minimal pathway where patients were required to self-isolate prior to admission and were swabbed for COVID-19 within 72 h of surgery. Positive patients had surgery deferred until a negative swab. At IEO, radical surgeries declined by 6% as compared to the same period in 2019 (n = 1477 vs. 1560, respectively). Readmissions were required for 3% (n = 41), and <1% (n = 9) developed COVID-19, of which only one had severe disease and died. At SELCA, radical surgeries declined by 34% (n = 1553 vs. 2336). Readmissions were required for 11% (n = 36), <1% (n = 7) developed COVID-19, and none died from it. Whilst a decline in number of surgeries was observed in both centres, the implemented COVID-19 minimal pathways have shown to be safe for cancer patients requiring radical treatment, with limited complications and almost no COVID-19 infections.

AB - The SARS-CoV-2 (COVID-19) pandemic is having a large effect on the management of cancer patients. This study reports on the approach and outcomes of cancer patients receiving radical surgery with curative intent between March and September 2020 (in comparison to 2019) in the European Institute of Oncology, IRCCS (IEO) in Milan and the South East London Cancer Alliance (SELCA). Both institutions implemented a COVID-19 minimal pathway where patients were required to self-isolate prior to admission and were swabbed for COVID-19 within 72 h of surgery. Positive patients had surgery deferred until a negative swab. At IEO, radical surgeries declined by 6% as compared to the same period in 2019 (n = 1477 vs. 1560, respectively). Readmissions were required for 3% (n = 41), and <1% (n = 9) developed COVID-19, of which only one had severe disease and died. At SELCA, radical surgeries declined by 34% (n = 1553 vs. 2336). Readmissions were required for 11% (n = 36), <1% (n = 7) developed COVID-19, and none died from it. Whilst a decline in number of surgeries was observed in both centres, the implemented COVID-19 minimal pathways have shown to be safe for cancer patients requiring radical treatment, with limited complications and almost no COVID-19 infections.

KW - Cancer surgery

KW - COVID-19

KW - Postoperative outcomes

UR - http://www.scopus.com/inward/record.url?scp=85103232119&partnerID=8YFLogxK

U2 - 10.3390/cancers13071597

DO - 10.3390/cancers13071597

M3 - Article

AN - SCOPUS:85103232119

SN - 2072-6694

VL - 13

JO - Cancers

JF - Cancers

IS - 7

M1 - 1597

ER -

Continuity of cancer care: The surgical experience of two large cancer hubs in london and milan

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this